Side effects with Wegovy 7.2 mg The STEP UP trial found that side effects were somewhat more common at the 7.2 mg dose than at 2.4 mg: 2 GI side effects: 70.8% (7.2 mg) vs 61.2% (2.4 mg) Dysaesthesia (tingling or numbness): 22.9% (7.2 mg) vs 6.0% (2.4 mg) Discontinuation due to side effects remained low at 3.3% The dysaesthesia finding is notable, though 85.7% of cases resolved while continuing treatment
Improved Glycemic Control : Tirzepatide is highly effective in lowering HbA1c levels, supporting better long-term blood sugar management for individuals with type 2 diabetes
A gradual climb from the starting dose to the maximum therapeutic dose
Some practical considerations: Evening injection some patients prefer injecting in the evening so they can sleep through any initial side effects like nausea Consistency matters most choosing the same day and roughly the same time each week helps maintain stable drug levels Injection sites abdomen, thigh, or upper arm, with rotation between sites to reduce injection-site reactions What about non-standard intervals (every 5 days)
That is more than double your intended dose
Factors affecting pricing include compounding pharmacy costs, active pharmaceutical ingredient availability and pricing, regulatory changes, operational expenses, market conditions, and individual patient circumstances